Zobrazeno 1 - 10
of 27
pro vyhledávání: '"V P Werth"'
Autor:
D F, Murrell, A, Patsatsi, P, Stavropoulos, S, Baum, T, Zeeli, J S, Kern, R, Sinclair, A, Neale, P, Arora, P B, Sugerman, G, Shi, V P, Werth, F, Caux, P, Joly
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fb92fa830620f1a0e9bf96fefed458f3
https://pubmed.ncbi.nlm.nih.gov/35686647
https://pubmed.ncbi.nlm.nih.gov/35686647
Autor:
J S S, Concha, S, Pena, R G, Gaffney, B, Patel, M, Tarazi, C J, Kushner, J F, Merola, D, Fiorentino, J P, Dutz, M, Goodfield, F, Nyberg, B, Volc-Platzer, M, Fujimoto, C C, Ang, V P, Werth, Yukie, Yamaguchi
Publikováno v:
British Journal of Dermatology. 182:410-417
Background The European League Against Rheumatism/American College of Rheumatology classification criteria for inflammatory myopathies are able to classify patients with skin-predominant dermatomyositis (DM). However, approximately 25% of patients wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fdead39371c868ea7e171edd1f39937
https://doi.org/10.1111/bjd.18096
https://doi.org/10.1111/bjd.18096
Publikováno v:
Annals of the Rheumatic Diseases. 81:711.2-711
BackgroundLimited therapies are available for patients with idiopathic inflammatory myopathy (IIM), a heterogenous group of chronic, systemic, autoimmune inflammatory diseases characterized by progressive muscle weakness and/or distinct skin rashes.1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0eec4ebb5863e18eeb843bfc79043f8f
https://doi.org/10.1136/annrheumdis-2022-eular.7
https://doi.org/10.1136/annrheumdis-2022-eular.7
Autor:
E. Morand, M. Pike, J. T. Merrill, R. Van Vollenhoven, V. P. Werth, C. Hobar, N. Delev, V. Shah, B. Sharkey, T. Wegman, I. Catlett, S. Banerjee, S. Singhal
Publikováno v:
Annals of the Rheumatic Diseases. 81:209-209
BackgroundTyrosine kinase 2 (TYK2) mediates signaling of Type I interferons, IL-23, and IL-12, key cytokines involved in lupus pathogenesis. Deucravacitinib (DEUC) is an oral, selective, allosteric TYK2 inhibitor with a unique mechanism of action, di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86576d747eb3ed8502b3432387fc8db9
https://doi.org/10.1136/annrheumdis-2022-eular.5020a
https://doi.org/10.1136/annrheumdis-2022-eular.5020a
Publikováno v:
Advances in clinical chemistry. 77
During apoptosis or activation, cells can release a subcellular structure, called a membrane microvesicle (also known as microparticle) into the extracellular environment. Microvesicles bud-off as a portion of cell membrane with its associated protei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7f327625e921f54c31d64e8a06ec4b3c
https://pubmed.ncbi.nlm.nih.gov/27717416
https://pubmed.ncbi.nlm.nih.gov/27717416
Autor:
N, Ruperto, L M, Hanrahan, G S, Alarcón, H M, Belmont, R L, Brey, P, Brunetta, J P, Buyon, M I, Costner, M E, Cronin, M A, Dooley, G, Filocamo, D, Fiorentino, P R, Fortin, A G, Franks, G, Gilkeson, E, Ginzler, C, Gordon, J, Grossman, B, Hahn, D A, Isenberg, K C, Kalunian, M, Petri, L, Sammaritano, J, Sánchez-Guerrero, R D, Sontheimer, V, Strand, M, Urowitz, J M, von Feldt, V P, Werth, J T, Merrill, Asad A, Zoma
Publikováno v:
Lupus. 20:453-462
The Lupus Foundation of America (LFA) convened an international working group to obtain a consensus definition of disease flare in lupus. With help from the Paediatric Rheumatology International Trials Organization (PRINTO), two web-based Delphi surv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99151cc15f8228b0ae7566ef672fc033
https://doi.org/10.1177/0961203310388445
https://doi.org/10.1177/0961203310388445
Autor:
C, Boulard, S, Duvert Lehembre, C, Picard-Dahan, J S, Kern, G, Zambruno, C, Feliciani, B, Marinovic, P, Vabres, L, Borradori, C, Prost-Squarcioni, B, Labeille, M A, Richard, S, Ingen-Housz-Oro, E, Houivet, V P, Werth, D F, Murrell, M, Hertl, J, Benichou, P, Joly, V, Ferranti
Publikováno v:
The British journal of dermatology. 175(1)
Two pemphigus severity scores, Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI), have been proposed to provide an objective measure of disease activity. However, the use of these scores in clinical prac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::90bb5eed297fe62acc01a8073a0261e8
https://pubmed.ncbi.nlm.nih.gov/27484271
https://pubmed.ncbi.nlm.nih.gov/27484271
Dermatology position paper on the revision of the 1982 ACR criteria for systemic lupus erythematosus
Autor:
J, Albrecht, J A, Berlin, I M, Braverman, J P, Callen, M K, Connolly, M I, Costner, J, Dutz, D, Fivenson, A G, Franks, J L, Jorizzo, L A, Lee, D P, McCauliffe, R D, Sontheimer, V P, Werth
Publikováno v:
Lupus. 13:839-849
The 1982 ACR classification criteria have become de facto diagnostic criteria for systemic lupus erythematosus (SLE), but a review of the criteria is necessary to include recent diagnostic tests. The criteria were not developed with the help of derma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba7995252bd1c9f1874b85127032c564
https://doi.org/10.1191/0961203304lu2020oa
https://doi.org/10.1191/0961203304lu2020oa
Autor:
S, Sabir, V P, Werth
Publikováno v:
Dermatologic Clinics. 18:437-446
High-dose intravenous (i.v.) methylprednisolone has been used therapeutically in a number of medical fields to avoid the complications and side effects of long-term glucocorticoid (GC) therapy and because of the perception that high-dose i.v. methylp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0c39cfd5ccb1151645cb81157e4ba46
https://doi.org/10.1016/s0733-8635(05)70192-3
https://doi.org/10.1016/s0733-8635(05)70192-3
Autor:
R, Vasquez, D, Wang, Q P, Tran, B, Adams-Huet, M-M, Chren, M I, Costner, J B, Cohen, V P, Werth, B F, Chong
Publikováno v:
The British journal of dermatology. 168(1)
A study at the University of Pennsylvania (UPenn) Medical Center demonstrated that quality of life in patients with cutaneous lupus erythematosus (CLE) is negatively impacted. Whether patients with CLE in other geographic locations have similar quali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6d4956e20f48d37861f308dd1596f846
https://pubmed.ncbi.nlm.nih.gov/22708924
https://pubmed.ncbi.nlm.nih.gov/22708924